[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 9628 Introduced in House (IH)]
<DOC>
118th CONGRESS
2d Session
H. R. 9628
To direct the Secretary of Defense to collaborate with a federally
funded research and development center to assess the biotechnology
capabilities of adversaries of the United States, and for other
purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
September 17, 2024
Mr. Khanna introduced the following bill; which was referred to the
Committee on Armed Services
_______________________________________________________________________
A BILL
To direct the Secretary of Defense to collaborate with a federally
funded research and development center to assess the biotechnology
capabilities of adversaries of the United States, and for other
purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Assessment of Critical Technologies
in Adversarial Ventures and Emerging Threats Act'' or the ``ACTIVATE
Act''.
SEC. 2. AUTHORITY FOR SECRETARY OF DEFENSE TO ENTER INTO AN AGREEMENT
FOR AN ASSESSMENT OF BIOTECHNOLOGY CAPABILITIES OF
ADVERSARIES OF THE UNITED STATES.
(a) In General.--Not later than 120 days after the date of the
enactment of this Act, the Secretary of Defense shall seek to enter
into an agreement with a federally funded research and development
center to conduct an assessment related to biotechnology and provide
recommendations to the Secretary.
(b) Agreement Elements.--Under an agreement between the Secretary
and a federally funded research and development center under this
section, the center shall agree to--
(1) conduct an assessment of--
(A) scientific topics related to biotechnology;
(B) scientific capabilities of potential
adversaries of the United States, such as China, Iran,
and the Russian Federation, related to biotechnology;
and
(C) the current gaps and future scientific and
technological needs for adversaries of the United
States to be successful with respect to biotechnology
capabilities; and
(2) develop recommendations with respect to useful
indications of any advancement of such adversaries regarding
such capabilities.
(c) Responsibilities of Secretary.--Under an agreement between the
Secretary and a federally funded research and development center under
this section, the Secretary shall agree to--
(1) appoint appropriate Department of Defense employees as
liaisons to the center to support the timely conduct of the
assessment described in subsection (b)(1);
(2) provide the center with access to materials relevant to
the conduct of such assessment, consistent with the protection
of sources and methods and other critically sensitive
information; and
(3) ensure that appropriate members and staff of the center
have the necessary clearances, obtained in an expedited manner,
to conduct such assessment.
(d) Report.--
(1) In general.--If the Secretary enters into an agreement
with a federally funded research and development center under
this section, not later than October 1, 2025, the Secretary
shall submit to the congressional defense committees and the
National Security Commission on Emerging Biotechnology a report
that includes the findings and recommendations of the center
developed pursuant to the assessment described in subsection
(b)(1).
(2) Form of report.--The report under paragraph (1) shall
be submitted in unclassified form, but may contain a classified
annex.
(3) Transmittal to other department entities.--The
Secretary shall transmit to relevant offices of the Department
of Defense, including the offices of the Under Secretary of
Defense for Acquisition and Sustainment, the Under Secretary of
Defense for Research and Engineering, the Under Secretary of
Defense for Policy, the Under Secretary of Defense for
Intelligence and Security, and the Office of Net Assessment, a
copy of the report under paragraph (1).
<all>